540
Views
28
CrossRef citations to date
0
Altmetric
Articles

Treatment of Atypical Pneumonia with Azithromycin: Comparison of a 5-Day and a 3-Day Course

Pages 64-68 | Published online: 18 Jul 2013

References

  • Bartlett JG, Mundy LM. Community-acquired pneumo-nia. N Engl J Med 1995; 333: 1618–1624.
  • Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Bennett JE, Raphael D, eds, Principles and prac-tice in infectious diseases. 4th ed. Vol. 1. New York: Churchill Livingstone, 1995: 619-637.
  • Marrie TJ, Haldane EV, Noble MA, Faulkner RS, Martin RS, Lee SHS. Causes of atypical pneumonia: results of a 1-year prospective study. Can Med Assoc J 1981; 125: 1118-1123.
  • Schlick W. The problems of treating atypical pneumo-nia. J Antimicrob Chemother 1993; 31: Suppl C: 111-120.
  • Wise R. The pharmacokinetics of azithromycin. Rev Contemp Pharmacother 1994; 5: 329–340.
  • Baldwin DR, Wise R, Andrews JM, Ashby JP, Honeybourne D. Azithromycin concentrations at the sites of pulmonary infections. Eur Respir J 1990; 3: 886–890.
  • Morris DI, De Souza A, Jones JA, Morgan WE. High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose. Eur J Clin Microbiol Infect Dis 1991; 10: 859–861.
  • Foulds G, Shepard RM, Johnson RB. The pharmacoki-netics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25: Suppl A: 73-82.
  • Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J Antimicrob Chemother 1990; 25: Suppl A: 39-50.
  • Welsh LE, Gaydos CA, Quinn TC. In vitro evaluation of activities of azithromycin, erythromycin and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother 1992; 36: 291–294.
  • Renaudin H, Bebear C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis 1990; 9: 838–841.
  • Edelstein PH. Antimicrobial chemotherapy for legion-naires' disease: a review. Clin Infect Dis 1995; 21: Suppl C: S265-276.
  • Fitzgeorge RB, Featherstone ASR, Baskerville A. Efficacy of azithromycin in the treatment of guinea pigs infect-ed with Legionella pneumophila by aerosol. J Antimicrob Chemother 1990; 25: Suppl A: 101-108.
  • Hoepelman AIM, Sips AP, van Helmond JLM et al. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infec-tions. J Antimicrob Chemother 1993; 25: Suppl E: 147-152.
  • Bradbury F. Comparison of azithromycin versus clar-ithromycin in the treatment of patients with lower respiratory tract infections. J Antimicrob Chemother 1993; 25: Suppl E: 153-162.
  • Kinasewitz G, Wood RG. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Eur J Clin Microbiol Infect Dis 1991; 10: 872–876.
  • Myburgh J, Nagel GJ, Petschel E. The efficacy and tol-erance of a three-day course of azithromycin in the treatment of community-acquired pneumonia. J Antimicrob Chemother 1993; 25: Suppl E: 163-169.
  • Schonwald S, Gunjaca M, Kolacny-Babic L, Car V, Gogev M. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonia. J Antimicrob Chemother 1990; 25: Suppl A: 101-108.
  • Schonwald S, gkerk V, Petricevic I, Car V, Majerus-Mi_ic II, Gunjaca M. Comparison of three-day and five-day azithromycin in the treatment of atypical pneumonia. Eur J Clin Microbiol Infect Dis 1991; 10: 877–880.
  • Kuzman I, Soldo I, Schonwald S, Culig J. Azithromycin for treatment of community-acquired pneumonia caused by Legionella pneumophila: a retrospective study. Scand J Infect Dis 1995; 27: 503–505.
  • Raoult D, Torres H, Drancourt M. Shell-vial assay: eval-uation of new technique for determining antibiotic susceptibili-ty, tested in 13 isolates of Coxiella burnetii. Antimicrob Agents Chemother 1991; 35: 2070–2077.
  • Marrie TJ. Coxiella burnetii (Q fever) pneumonia. Clin Infect Dis 1995; 21: Suppl 3: S253–64.
  • Perez-del-Molino A, Aguado JM, Riancho JA, Sampedro I, Matorras P, Gonzales-Macias J. Erythromycin and the treatment of Coxiella burnetii pneumonia. J Antimicrob Chemother 1991; 28: 455–459.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.